{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:22:55Z","timestamp":1790792575597,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.bioorg.2022.105864","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T11:15:49Z","timestamp":1652181349000},"page":"105864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Discovery of 4-methoxy-N-(1-naphthyl)benzenesulfonamide derivatives as small molecule dual-target inhibitors of tubulin and signal transducer and activator of transcription 3 (STAT3) based on ABT-751"],"prefix":"10.1016","volume":"125","author":[{"given":"Xuebao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doudou","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinheng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijun","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixia","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanxi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigui","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faqing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2022.105864_b0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1568026615666150112115805","article-title":"Tubulins - the target for anticancer therapy","volume":"15","author":"Vindya","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105864_b0010","article-title":"Post-translational modifications of tubulin: their role in cancers and the regulation of signaling molecules","author":"Wattanathamsan","year":"2021","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105864_b0015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tcb.2018.08.003","article-title":"The Tubulin Detyrosination Cycle: Function and Enzymes","volume":"29","author":"Nieuwenhuis","year":"2019","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bioorg.2022.105864_b0020","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.2147\/OTT.S229076","article-title":"Connexin 43 Modulates the Cellular Resistance to Paclitaxel via Targeting \u03b2-Tubulin in Triple-Negative Breast Cancer","volume":"13","author":"Fu","year":"2020","journal-title":"OncoTargets and therapy"},{"issue":"7","key":"10.1016\/j.bioorg.2022.105864_b0025","doi-asserted-by":"crossref","first-page":"11938","DOI":"10.1021\/acsomega.9b00947","article-title":"Structural Basis and Mechanism for Vindoline Dimers Interacting with \u03b1, \u03b2-Tubulin","volume":"4","author":"Zhang","year":"2019","journal-title":"ACS Omega"},{"issue":"8","key":"10.1016\/j.bioorg.2022.105864_b0030","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1158\/1535-7163.MCT-09-0366","article-title":"Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance","volume":"8","author":"Perez","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105864_b0035","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1517\/13543784.9.4.779","article-title":"Mechanisms of action and resistance to tubulin-binding agents","volume":"9","author":"Dumontet","year":"2000","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"Pt 3","key":"10.1016\/j.bioorg.2022.105864_b0040","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1042\/bj3440797","article-title":"Interferon-gamma-dependent stimulation of human involucrin gene expression: STAT1 (signal transduction and activators of transcription 1) protein activates involucrin promoter activity","volume":"344","author":"Takahashi","year":"1999","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105864_b0045","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.263","article-title":"The IL-6-STAT3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression","volume":"5","author":"Zhu","year":"2014","journal-title":"Cell Death Dis."},{"issue":"57","key":"10.1016\/j.bioorg.2022.105864_b0050","doi-asserted-by":"crossref","first-page":"97260","DOI":"10.18632\/oncotarget.21919","article-title":"Expression of miR-195 is associated with chemotherapy sensitivity of cisplatin and clinical prognosis in gastric cancer","volume":"8","author":"Ye","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105864_b0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1040-8428(03)00171-9","article-title":"The pipeline of new anticancer agents for breast cancer treatment in 2003","volume":"48","author":"Awada","year":"2003","journal-title":"Critical reviews in oncology \/hematology"},{"issue":"4","key":"10.1016\/j.bioorg.2022.105864_b0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ajoms.2011.06.007","article-title":"STAT3 as a target of molecular targeting therapy for oral cancer: Cell-based screening using inhibitor screening kits","volume":"23","author":"Nagumo","year":"2011","journal-title":"Asian Journal of Oral and Maxillofacial Surgery"},{"issue":"7","key":"10.1016\/j.bioorg.2022.105864_b0065","doi-asserted-by":"crossref","DOI":"10.5483\/BMBRep.2019.52.7.152","article-title":"Highlighted STAT3 as a potential drug target for cancer therapy","volume":"52","author":"Lee","year":"2019","journal-title":"BMB Reports"},{"issue":"23","key":"10.1016\/j.bioorg.2022.105864_b0070","article-title":"Targeting STAT3 in cancer and autoimmune diseases","volume":"878","author":"Gharibi","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.bioorg.2022.105864_b0075","article-title":"Raloxifene inhibits IL-6\/STAT3 signaling pathway and protects against high-fat-induced atherosclerosis in ApoE\/ mice","volume":"261","author":"Luo","year":"2020","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105864_b0080","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.bbadis.2019.01.016","article-title":"Glaucocalyxin A-induced oxidative stress inhibits the activation of STAT3 signaling pathway and suppresses osteosarcoma progression in vitro and in vivo, Biochimica et biophysica acta","volume":"1865","author":"Mao","year":"2019","journal-title":"Molecular basis of disease"},{"issue":"16","key":"10.1016\/j.bioorg.2022.105864_b0085","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1021\/acs.jmedchem.5b00659","article-title":"N-Sulfonyl-aminobiaryls as Antitubulin Agents and Inhibitors of Signal Transducers and Activators of Transcription 3 (STAT3) Signaling","volume":"58","author":"Lai","year":"2015","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105864_b0090","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10616-021-00462-7","article-title":"Propofol inhibits proliferation, migration, invasion and promotes apoptosis by regulating HOST2\/JAK2\/STAT3 signaling pathway in ovarian cancer cells","volume":"73","author":"Shen","year":"2021","journal-title":"Cytotechnology"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105864_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2017.11.023","article-title":"N-Arylsulfonylsubstituted-1H indole derivatives as small molecule dual inhibitors of signal transducer and activator of transcription 3 (STAT3) and tubulin","volume":"26","author":"Zhou","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105864_b0100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/CAD.0b013e32832c0acf","article-title":"ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature","volume":"20","author":"Luo","year":"2009","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.bioorg.2022.105864_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.730257","article-title":"Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy","volume":"12","author":"L\u00f6scher","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105864_b0110","first-page":"631","article-title":"A phase II study of ABT-751 in patients with advanced non-small cell lung cancer, Journal of thoracic oncology : official publication of the International Association for the Study of","volume":"3","author":"Mauer","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bioorg.2022.105864_b0115","doi-asserted-by":"crossref","unstructured":"S.Z. Dehghanian, C.-T. Pan, J.M. Lee, Y.-L. Shiue, ABT-751 Induces Multiple Anticancer Effects in Urinary Bladder Urothelial Carcinoma-Derived Cells: Highlighting the Induction of Cytostasis through the Inhibition of at Both Transcriptional and Post-Translational Levels, International journal of molecular sciences 22(2) (2021), https:\/\/doi.org\/10.3390\/ijms22020945.","DOI":"10.3390\/ijms22020945"},{"issue":"8","key":"10.1016\/j.bioorg.2022.105864_b0120","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/jcph.681","article-title":"Phase 1 Study of ABT-751 in Combination With CAPIRI (Capecitabine and Irinotecan) and Bevacizumab in Patients With Advanced Colorectal Cancer","volume":"56","author":"Rudek","year":"2016","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bioorg.2022.105864_b0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-pharmtox-010715-103715","article-title":"The Cellular Thermal Shift Assay: A Novel Biophysical Assay for In Situ Drug Target Engagement and Mechanistic Biomarker Studies","volume":"56","author":"Martinez Molina","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"8","key":"10.1016\/j.bioorg.2022.105864_b0130","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/CAD.0000000000000783","article-title":"C188\u20139, a small-molecule STAT3 inhibitor, exerts an antitumor effect on head and neck squamous cell carcinoma","volume":"30","author":"Di","year":"2019","journal-title":"Anticancer Drugs"},{"issue":"2","key":"10.1016\/j.bioorg.2022.105864_b0135","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1039\/C7MD00416H","article-title":"Molecular modeling study, synthesis and biological evaluation of combretastatin A-4 analogues as anticancer agents and tubulin inhibitors","volume":"9","author":"Quan","year":"2018","journal-title":"MedChemComm"},{"key":"10.1016\/j.bioorg.2022.105864_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114069","article-title":"Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities","volume":"229","author":"Sun","year":"2022","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822002693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822002693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:32:58Z","timestamp":1758616378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206822002693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":28,"alternative-id":["S0045206822002693"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105864","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 4-methoxy-N-(1-naphthyl)benzenesulfonamide derivatives as small molecule dual-target inhibitors of tubulin and signal transducer and activator of transcription 3 (STAT3) based on ABT-751","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105864","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105864"}}